肝豆状核变性患者角膜K-F环与临床病情程度关系探讨*

doi:10.3969/j.issn.1672-5069.2024.01.037

Abstract

Chen Fenfen, Hu Fengyun, Cao Xiaoli, et al. Response to D-penicillamine treatment in patients with Wi1son's disease and different degree of Kayser-Fleischer ring[J]. Journal of Practical Hepatology, 2024, 27(1): 145-147.

References

[1] Członkowska A, Litwin T, Dusek P, et al. Wilson disease. Nat Rev Dis Primers, 2018, 4(1): 21.
[2] 中华医学会神经病学分会神经遗传学组. 中国肝豆状核变性诊治指南(2021年). 中华神经科杂志, 2021, 54(4): 310-319.
[3] 中华医学会神经病学分会帕金森病暨运动障碍学组, 中华医学会神经病学分会神经遗传病学组. 肝豆状核变性的诊断和治疗指南. 中华神经科杂志, 2008, 41(8): 566-569.
[4] 杨锡强,易著文,儿科学,6版,北京:人民卫生出版社,2004:173.
[5] 黄芳,黄丽,李洵桦.角膜K-F环对肝豆状核变性的诊断价值.中国现代医学杂志,2013,23(3):44-47.
[6] 罗继红,梁娜.角膜K-F环与WD关系的临床分析.中西医结合肝病杂志,2011,21(4):241-242.
[7] Guttmann S,Bernick F,Naorniakowska M,et al. Functional characterization of novel ATP7B variants for diagnosis of Wilson disesas. Front Pediatr,2018,6:106.
[8] Bandmann O,Weiss KH,Kaler SG. Wi1son's disease and other neurological copper disorders. Lancet Neurol,2015,14(1):103-113.
[9] Merle U,Schaefer M,Ferenci P,et al.Clinical presentation,diagnosis and long-term outcome of Wilson’s disease:a cohort study .Gut,2007,56(1):115-120.
[10] 霍丽君,廖瑞瑞,陈雪梅.Wilson病的眼病表现.中华神经科杂志,2008,44(2):128-130.
[11] European Association for Study of Liver. EASL Clinical Practice Guidelines: Wilson’s disease. J Hepatol,2012,56(3):671-685.
[12] Palumbo CS, Schilsky ML. Clinical practice guidelines in Wilson disease. Ann Transl Med Med,2019,7(Suppl 2):S65.
[13] Herrera-Quiñones G, Da Fieno AM, Compta Y, et al. Considerations for optimizing Wilson's disease patients' long-term follow-up. Gastroenterol Hepatol,2022,45(2):146-154.
[14] Polishchuk EV,Concilli M,Iacobacci S,et al.Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis.Del Cell,2014,29(6):686-700.
[15] Socha P, Janczyk W, Dhawan A, et al. Wilson’s disease in children: A position paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr,2018,66(2):334-344.
[16] Mohr I, Weiss KH. Biochemical markers for the diagnosis and monitoring of Wilson Disease. Clin Biochem Rev,2019,40(2):59-77.
[17] 张亦瑾,高学松等.儿童与成人肝豆状核变性患者临床特征和生存分析.实用肝脏病杂志,2023,26(4):520-523.
[18] Xie JJ, Wu ZY. Wilson disease in China. Neurosci Bull,2017,33(3):323-330.

Response to D-penicillamine treatment in patients with Wi1son's disease and different degree of Kayser-Fleischer ring

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Chen Congxin, Chen Xi, Wang Liping, et al. How to administrate steroids to patients with cholestasis and liver failure？ [J]. Journal of Practical Hepatology, 2024, 27(3): 321-323.
[2]	Zhao Yuwen, Zhu Chuanlong. Management of malnutrition and sarcopenia in patients with liver cirrhosis [J]. Journal of Practical Hepatology, 2024, 27(3): 324-328.
[3]	Luo Liangde, Ren Chengguo, Wang Shoujun, et al. Combination of entecavir and polyene phosphatidylcholine therapy in the treatment of patients with chronic hepatitit B and NASH [J]. Journal of Practical Hepatology, 2024, 27(3): 333-336.
[4]	Zhou Anqi, Meng Shuting, Wu Yingdong, et al. Low level viremia in patients with chronic hepatitis B receiving nucleos(t)ide analogue treatment [J]. Journal of Practical Hepatology, 2024, 27(3): 337-340.
[5]	Cheng Yanjie, Wang Pengfei, Li Jun. Clinical efficacy of silymarin and compound methionine choline combination in the treatment of patients with alcoholic hepatitis [J]. Journal of Practical Hepatology, 2024, 27(3): 349-352.
[6]	Xu Qiuping, Huang Bin, Chen Min, et al. Changes of peripheral blood MDSCs, serum CD38 level and hepatic interleukin-35 expression in patients with autoimmune hepatitis receiving prednisone and azathioprine combination therapy [J]. Journal of Practical Hepatology, 2024, 27(3): 374-377.
[7]	Jiang Zhengwei, Zhou Bingqing, Tang Jie, et al. Clinical feature of primary biliary cholangitis patients with serum anti glycoprotein 210 antibody positive [J]. Journal of Practical Hepatology, 2024, 27(3): 378-381.
[8]	Li Julan, Zhang Huatang, Zheng Yijuan, et al. Chinese herbal medicine compound,Fuzheng Huayu table, ameliorate liver fibrosis in patients with hepatitis B-induced liver cirrhosis receiving entecavir antiviral treatment [J]. Journal of Practical Hepatology, 2024, 27(3): 402-405.
[9]	Cai Junling, Su Li, Hao Li, et al. Efficacy of antiviral therapy based on sorfosbuvir combination in the treatment of patients with hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2024, 27(3): 406-409.
[10]	Yan Zhen, Zhao Bowen, Lin Guoying, et al. Clinical application of imaging three-dimensional visualization technique in guidance of hepatectomy in patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2024, 27(3): 438-441.
[11]	Li Weijian, Liu Xin, Shu Hongyan. Comparison of lauromacrogol and anhydrous ethanol sclerotherapy under ultrasound guidance in the treatment of patients with hepatic cysts [J]. Journal of Practical Hepatology, 2024, 27(3): 450-453.
[12]	Wang Lingru, Su Hong, Hao Xiaowei, et al. Disappearance of simple hepatic cysts after percutaneous transhepatic gallbladder drainage and lauromacrogol sclerotherapy under ultrasound guidance: A single center observation [J]. Journal of Practical Hepatology, 2024, 27(3): 454-457.
[13]	Ma Ruidong, Luo Shiqiao. Hepatic arterial infusion pump chemotherapy in treatment of patients with colorectal liver metastases [J]. Journal of Practical Hepatology, 2024, 27(3): 473-476.
[14]	Xu Xu, Shi Yiwen, Fan Jiangao. Treatment of hepatolenticular degeneration:Status and prospective [J]. Journal of Practical Hepatology, 2024, 27(3): 477-480.
[15]	Li Xingquan, Yang Chun, Li Shiyuan, et al.. Virological response of patients with genotype 1b infected chronic hepatitis C to combination of ombitasvir and dasabuvir antiviral therapy [J]. Journal of Practical Hepatology, 2024, 27(2): 177-180.